Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EuroEyes International Eye ClinicHKSE:01846 +0.42%81 Buyback Yield % is 2.41 as of Sep. 02, 2026, which is 503% above its 10-year median of 0.40. GuruFocus rates HKSE:01846 with a GF Score™ of 81/100 and a GF Value™ of HK$5.61 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 243 Healthcare Providers & Services companies, EuroEyes International Eye Clinic ranks better than 82.3% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic Buyback Yield % Chart
HKSE:01846 vs HCA, THC, EHC: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic (HKSE:01846) has a Buyback Yield % of 2.41 as of Sep. 02, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on EuroEyes International Eye Clinic and its competitors. This is 503% above median its historical median of 0.40. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #43 out of 243 companies in the Healthcare Providers & Services industry, placing it in the top 17.7%.
Is EuroEyes International Eye Clinic's Buyback Yield % too high?
EuroEyes International Eye Clinic's current Buyback Yield % of 2.41 is 503% above median its 10-year median of 0.40. Based on the distribution chart, EuroEyes International Eye Clinic ranks #43 out of 243 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, EuroEyes International Eye Clinic has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #43 out of 243 companies for Buyback Yield %. This places EuroEyes International Eye Clinic in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on EuroEyes International Eye Clinic and its competitors. EuroEyes International Eye Clinic's current Buyback Yield % is 2.41, which is 503% above median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.61, compared to a current price of HK$2.38 — trading 57.6% below its estimated fair value. The current Buyback Yield % is 2.41, which is 503% above median its 10-year median of 0.40. EuroEyes International Eye Clinic's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current Buyback Yield % is 2.41 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.38 is trading 57.6% below its estimated GF Value™ of HK$5.61.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
Buyback Yield %: 2.41 (503% above median its 10-year median of 0.40)
GF Value™: HK$5.61 vs. price of HK$2.38 (57.6% below fair value)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
81GF Score
Get the complete analysis for HKSE:01846
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
